<DOC>
	<DOCNO>NCT02777957</DOCNO>
	<brief_summary>First , aim study evaluate usefulness echocardiographic parameter detect pulmonary hypertension ( PH ) patient advanced lung disease refer lung transplantation . Second , assess prevalence PH identify hemodynamic , echocardiographic , pulmonary functional test , exercise capacity biochemical parameter ( especially NT-proBNP ) impact survival cohort patient severe lung disease refer lung transplantation .</brief_summary>
	<brief_title>Predictors Pulmonary Hypertension Patients With Advanced Lung Diseases</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>advanced lung disease qualification lung transplantation write informed consent pulmonary capillary wedge pressure &lt; 15 mmHg cancer , history idiopathic pulmonary hypertension , primary valvular heart disease , coronary artery disease , collagen vascular disease , history evidence leave ventricular dysfunction , atrial fibrillation , increase liver enzyme level ( 3 time upper laboratory limit ) , renal dysfunction ( estimate glomerular filtration rate &lt; 60 ml/min/1.73m2 ) patient n't write personal informed consent specific therapy PH .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Echocardiography</keyword>
	<keyword>Lung Transplantation</keyword>
</DOC>